RESEARCHER PROFILE

Bushra Bashir

← Back to Allama Iqbal Medical College

B

Allama Iqbal Medical College

Alzheimer's disease research and treatmentsSynthesis and biological activityAdvanced Drug Delivery SystemsStructural and Chemical Analysis of Organic and Inorganic CompoundsDrug Solubulity and Delivery Systems

Bushra Bashir works in Alzheimer's disease research and treatments, Synthesis and biological activity, Advanced Drug Delivery Systems, Structural and Chemical Analysis of Organic and Inorganic Compounds, Drug Solubulity and Delivery Systems. Recorded institutional associations include Lovely Professional University, Islamia University of Bahawalpur, Allama Iqbal Medical College.

116Publications
1,132Citations
16H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. CuxNi1-xO nanostructures and their nanocomposites with reduced graphene oxide: Synthesis, characterization, and photocatalytic applications

    2020 · 149 citations
  2. Copper doped manganese ferrites nanoparticles anchored on graphene nano-sheets for high performance energy storage applications

    2016 · 148 citations
  3. Mn1-xCuxO2/ reduced graphene oxide nanocomposites: Synthesis, characterization, and evaluation of visible light mediated catalytic studies

    2020 · 106 citations
  4. Copper substituted nickel ferrite nanoparticles anchored onto the graphene sheets as electrode materials for supercapacitors fabrication

    2018 · 92 citations
  5. Electrical, magnetic and photoelectrochemical activity of rGO/MgFe2O4 nanocomposites under visible light irradiation

    2016 · 67 citations
  6. Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices

    2024 · 43 citations
  7. Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects

    2025 · 39 citations
  8. Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation

    2024 · 38 citations
  9. Rare earth Tb3+ doped LaFeO3 nanoparticles: New materials for high frequency devices fabrication

    2015 · 30 citations
  10. Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies

    2020 · 30 citations
  11. Synthesis, characterization and studies of various structural, physical, magnetic, electrical and dielectric parameters for La1−xDyxNi1−yMnyO3 nanoparticles

    2013 · 23 citations
  12. Identification of phenylcarbamoylazinane-1,3,4-oxadiazole amides as lipoxygenase inhibitors with expression analysis and in silico studies

    2021 · 23 citations
  13. Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies

    2021 · 20 citations
  14. Harnessing the neuroprotective effect of oral administration of benfotiamine in MPTP induced Parkinson's disease in rats

    2023 · 20 citations
  15. Neuroprotective Role of Phytoconstituents-based Nanoemulsion for the Treatment of Alzheimer’s Disease

    2024 · 19 citations
  16. Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies

    2022 · 16 citations
  17. Enhancing the oral bioavailability of fisetin: polysaccharide-based self nano-emulsifying spheroids for colon-targeted delivery

    2024 · 15 citations
  18. Formulation and optimization of fisetin nanoemulsion for the treatment of Alzheimer's disease in rats: Pharmacokinetic and pharmacodynamic assessment

    2024 · 13 citations
  19. An overview of hyphenated techniques used for the identification of genotoxic impurities in pharmaceutical products: Current status and future perspectives

    2024 · 12 citations
  20. Does drug repurposing bridge the gaps in management of Parkinson’s disease? Unravelling the facts and fallacies

    2025 · 11 citations
  21. Tailoring the biomarkers of Alzheimer’s disease using a gut microbiome-centric approach: Preclinical, clinical, and regulatory perspectives

    2025 · 11 citations
  22. Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: Design, synthesis, DFT calculations and molecular docking studies

    2023 · 10 citations
  23. Investigating the potential of 1,2,4-triazoles as corrosion inhibitors for copper and steel: A comprehensive review

    2024 · 10 citations
  24. Microencapsulation of ultrasound-extracted betalains: Invitro anti-oxidant activity, thermal behavior & release profile

    2025 · 10 citations
  25. Dosimetry Characterization of Unknown Dye Polyvinyl Alcohol Films

    2012 · 9 citations

← Return to the university profile